NEXENTIS TECHNOLOGIES INC. Increase (Decrease) in Other Deferred Liability
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Increase (Decrease) in Other Deferred Liability of $173.36 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherDeferredLiability · last filed 2024-04-01
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other deferred liability for the quarter ending 2023-12-31 was $238.39K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other deferred liability for the quarter ending 2023-09-30 was $29.37K, a 19.36% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other deferred liability for the quarter ending 2023-06-30 was -$75.73K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other deferred liability for the quarter ending 2023-03-31 was -$18.66K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other deferred liability for fiscal 2023 was $173.36K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other deferred liability for fiscal 2022 was -$112.08K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in other deferred liability for fiscal 2021 was -$158.01K.
| Period end | Increase (Decrease) in Other Deferred Liability 3 month | Increase (Decrease) in Other Deferred Liability 6 month | Increase (Decrease) in Other Deferred Liability 9 month | Increase (Decrease) in Other Deferred Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | $238.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $267.75K derived: sum of 2 quarters · filed 2024-04-01 | $192.02K derived: sum of 3 quarters · filed 2024-04-01 | $173.36K 10-K · filed 2024-04-01 |
| 2023-09-30 | $29.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$46.36K derived: sum of 2 quarters · filed 2023-11-14 | -$65.03K 10-Q · filed 2023-11-14 | -$89.14K derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-06-30 | -$75.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$94.39K 10-Q · filed 2023-08-14 | -$118.50K derived: sum of 3 quarters · filed 2024-04-01 | -$93.90K derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-03-31 | -$18.66K 10-Q · filed 2023-05-15 | -$42.77K derived: sum of 2 quarters · filed 2024-04-01 | -$18.17K derived: sum of 3 quarters · filed 2024-04-01 | -$123.56K derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | -$24.11K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $496.00 derived: sum of 2 quarters · filed 2024-04-01 | -$104.90K derived: sum of 3 quarters · filed 2024-04-01 | -$112.08K 10-K · filed 2024-04-01 |
| 2022-09-30 | $24.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$80.79K derived: sum of 2 quarters · filed 2023-11-14 | -$87.97K 10-Q · filed 2023-11-14 | -$189.43K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$105.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$112.58K 10-Q · filed 2023-08-14 | -$214.03K derived: sum of 3 quarters · filed 2023-08-14 | -$623.13K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$7.18K 10-Q · filed 2023-05-15 | -$108.63K derived: sum of 2 quarters · filed 2023-05-15 | -$517.74K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$101.45K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$510.56K derived: sum of 2 quarters · filed 2023-03-27 | -$158.01K 10-K · filed 2023-03-27 | |
| 2021-09-30 | -$409.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$56.56K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $352.55K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |